Employee Benefits and Stock Compensation (Tables)

12 Months Ended

Dec. 31, 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The impact of share-based compensation on the Company’s financial results is presented below:

	For the Year Ended December 31,
(In thousands)	2017		2016		2015
Share-based compensation expense	$	5,267	$	4,154		2,859
Income tax benefit		(1,966)		(1,602)		(963)

Schedule of Unrecognized Compensation Cost, Nonvested Awards

The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2017 is presented below:

(In thousands)	Unrecognized Compensation Cost		Weighted- Average Period Remaining (Years)
Restricted stock awards	$	2,383		1.7
Restricted stock units		3,403		1.7
Stock options		1,374		2.4
Total	$	7,160		1.8

Schedule of Nonvested Share Activity

A summary of the status of the Company’s non-vested RSUs as of December 31, 2017, and changes during the year then ended, is presented below:

(In thousands, except share and per share data)	Restricted Award Shares		Weighted- Average Grant- Date Fair Value
Non-vested at January 1, 2017		206,952	$	14.72
Granted		114,331		24.08
Forfeited/Cancelled		(8,733)		20.76
Vested		(99,574)		14.13
Non-vested at December 31, 2017		212,976		19.77

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

Information regarding restricted stock awards during each of the following years:

(In thousands, except share and per share data)	Year Ended December 31,
	2017		2016		2015
Shares granted		114,331		164,599		123,806
Weighted-average grant date fair value	$	24.08	$	16.03	$	15.03
Fair value of awards vested(1)	$	1,407	$	1,981	$	836
(1) Based on grant date fair value

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company estimated the fair value of each option grant on the date of grant using the Black-Scholes options-pricing model with the following weighted-average assumptions:

	For the Year Ended December 31,
	2017			2016			2015
Risk-free interest rates		1.85	%		1.63	%		1.65	%
Expected dividend yield		0	%		0	%		0	%
Expected volatility		25.4	%		21.9	%		15.5	%
Expected lives (years)		5.0			5.0			5.0

Schedule of Stock Options Roll Forward

A summary of the Company’s stock options as of December 31, 2017, and changes during the year then ended, are presented below:

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (000s)
Outstanding at January 1, 2017		778,778	$	15.86
Granted		297,576		28.21
Exercised		(91,468)		11.77
Forfeited		(33,537)		96.17
Outstanding at December 31, 2017		951,349		17.29		6.86	$	8,493
Exercisable at December 31, 2017		517,100		12.09		5.85		6,787

Schedule of Share-based Compensation, Stock Options, Activity

Information related to stock options during each of the following years:

(In thousands, except share and per share data)	For the Year Ended December 31,
	2017		2016		2015
Options granted		297,576		243,391		63,650
Weighted-average grant date fair value	$	4.66	$	3.41	$	2.21
Intrinsic value of stock options exercised		1,143		80		-

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

The following table summarizes information related to stock options as of December 31, 2017:

Range of Exercise Prices	Options Outstanding		Remaining Contractual Life (Years)		Shares Exercisable		Weighted Average Exercise Price
$10.54 to $10.78		330,000		5.8		330,000	$	10.67
$10.97 to $15.99		323,773		5.8		163,538		13.42
$22.65 to $28.69		297,576		9.2		23,562		22.65
Total		951,349		6.9		517,100	$	12.09

Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity

The Employee Stock Purchase Plan (“ESPP”), as amended, was approved by shareholders on April 25, 1989, and additional shares were authorized for issuance by shareholders on June 18, 2009 and May 2, 2013. Under the ESPP, the Company is authorized to issue up to 300,000 common shares of the Company’s common stock to eligible employees of the Company.  These shares may be purchased by employees at a price equal to 95% of the fair market value of the shares on the purchase date.  Purchases under the ESPP are made monthly.  Employee contributions to the ESPP are made through payroll deductions.

	2017		2016		2015
ESPP shares purchased		12,434		10,483		9,083
Weighted-average employee purchase price	$	22.67	$	16.02	$	13.99

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of the status of the Company’s non-vested RSUs as of December 31, 2017, and changes during the year then ended, is presented below:

(In thousands, except share and per share data)	Restricted Award Shares		Weighted- Average Grant- Date Fair Value
Non-vested at January 1, 2017		322,692	$	12.61
Granted		164,268		21.61
Forfeited/Cancelled		(22,113)		13.79
Vested		(88,880)		10.54
Non-vested at December 31, 2017		375,967		16.96

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

Information regarding restricted stock units during the following years:

(In thousands, except share and per share data)	For the Year Ended December 31,
	2017		2016		2015
Shares granted		164,268		136,188		127,128
Weighted-average grant date fair value	$	23.94	$	13.53	$	12.63
Fair value of awards vested(1)	$	937	$	846	$	-
(1) Based on grant date fair value